CAS: 100898-63-3 - 5'-O-(4,4'-Dimethoxytrityl)-N4-acetyl-2'-deoxycytidine
Fórmula:C32H33N3O7
- Sinónimos:
- N4-Acetyl-2'-deoxy-5'-O-DMT-D-cytidine
- N4-Acetyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxycytidine
- 5'-O-(4,4'-Dimethoxytrityl)-N4-acetyl-2'-deoxycytidine (synthetic)
- Dmt-Ac-dC
- 5'-DMTr-N4-acetyl-2'-deoxycytidine
Cytidine, N-acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-
CAS:100898-63-3
Fórmula:
C32H33N3O7
Pureza:
96%
Forma y color:
Solid
Peso molecular:
571.6203
Ref: IN-DA00033R
1g | 26,00 € | ||
5g | 58,00 € | ||
25g | 150,00 € |
Entrega estimada en Estados Unidos, el Jueves 9 de Enero de 2025
Ref: 7W-GN3309
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Viernes 10 de Enero de 2025
5'-O-DMT-N4-Ac-dC
CAS:100898-63-3
5'-O-DMT-N4-Ac-dC, or compound 7, is a deoxynucleoside for making dod-DNA with hydrophobic regions.
Fórmula:
C32H33N3O7
Forma y color:
Liquid
Peso molecular:
571.62
Ref: TM-T37147
500mg | 48,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
Ref: 54-OR1014216
1g | 32,00 € | ||
5g | 56,00 € | ||
25g | 237,00 € | ||
100g | 866,00 € |
Entrega estimada en Estados Unidos, el Jueves 16 de Enero de 2025
N4-Acetyl-2'-deoxy-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-cytidine
CAS:100898-63-3
N4-Acetyl-2'-deoxy-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-cytidine is a novel anticancer agent that is modified with a phosphoramidite. It is a …
Fórmula:
C32H33N3O7
Pureza:
Min. 98 Area-%
Peso molecular:
571.62 g/mol
Ref: 3D-W-200637
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
N4-Acetyl-2'-deoxy-5'-O-DMT-cytidine
CAS:100898-63-3
N4-Acetyl-2'-deoxy-5'-O-DMT-cytidine is a potent and selective inhibitor of the receptor tyrosine kinases Cck-A, which is …
Fórmula:
C32H33N3O7
Pureza:
Min. 95%
Forma y color:
White Powder
Peso molecular:
571.62 g/mol
Ref: 3D-NA04015
5g | 159,00 € | ||
10g | 214,00 € | ||
25g | 380,00 € | ||
50g | 587,00 € | ||
100g | 901,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025